Cargando…
Trans-(−)-Kusunokinin: A Potential Anticancer Lignan Compound against HER2 in Breast Cancer Cell Lines?
Trans-(−)-kusunokinin, an anticancer compound, binds CSF1R with low affinity in breast cancer cells. Therefore, finding an additional possible target of trans-(−)-kusunokinin remains of importance for further development. Here, a computational study was completed followed by indirect proof of specif...
Autores principales: | Rattanaburee, Thidarath, Tanawattanasuntorn, Tanotnon, Thongpanchang, Tienthong, Tipmanee, Varomyalin, Graidist, Potchanapond |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8348432/ https://www.ncbi.nlm.nih.gov/pubmed/34361688 http://dx.doi.org/10.3390/molecules26154537 |
Ejemplares similares
-
Trans-(±)-Kusunokinin Binding to AKR1B1 Inhibits Oxidative Stress and Proteins Involved in Migration in Aggressive Breast Cancer
por: Tanawattanasuntorn, Tanotnon, et al.
Publicado: (2022) -
Effects of trans-(±)-kusunokinin on chemosensitive and chemoresistant ovarian cancer cells
por: Mad-Adam, Nadeeya, et al.
Publicado: (2022) -
(−)-Kusunokinin as a Potential Aldose Reductase
Inhibitor: Equivalency Observed via AKR1B1 Dynamics Simulation
por: Tanawattanasuntorn, Tanotnon, et al.
Publicado: (2020) -
Anticancer Activity of (±)-Kusunokinin Derivatives towards Cholangiocarcinoma Cells
por: Rattanaburee, Thidarath, et al.
Publicado: (2022) -
Trans-(±)-TTPG-B Attenuates Cell Cycle Progression and Inhibits Cell Proliferation on Cholangiocarcinoma Cells
por: Rattanaburee, Thidarath, et al.
Publicado: (2023)